Anti-hypertension drug may improve schizophrenia symptoms

May 9, 2013 by Raquel Maurier, University of Alberta

(Medical Xpress)—An anti-hypertension drug administered intravenously for a single four-hour treatment resulted in dramatic improvements of symptoms for people living with schizophrenia, according to newly published findings from clinician scientists at the University of Alberta's medical school and their colleagues in Brazil.

The results from the small clinical trial were published May 8 in the peer-reviewed journal, JAMA Psychiatry. The study involved 20 people with taking currently available . Ten received placebo treatments; the other 10 received low doses of the anti- sodium nitroprusside. Those taking the drug, which has been around since the 1800s, experienced dramatic improvements in symptoms, such as fewer (episodes of hearing voices), and less anxiety, depression and withdrawal. These improvements lasted for a month.

The small study was conducted at a university teaching hospital in Brazil, where principal investigator James Hallak works. The other principal investigator is Serdar Dursun, a researcher with the Faculty of Medicine & Dentistry who works in the Department of Psychiatry at the U of A.

In previous research in which Dursun was involved, his team saw promising results in lab models given the drug, originally marketed for treating severely high blood pressure. He was curious whether similar results would occur in people and teamed up with a colleague from Brazil to find out.

"This opens a new line of research for the treatment of schizophrenia," says Dursun. "Such rapid improvement of symptoms of schizophrenia could be very important to help patients in acute care and emergency settings."

Research team members believe the drug modifies how two chemical messengers in the brain interact.

Dursun and his colleagues are continuing their research in this area. They hope to secure more funding to conduct larger-scale .

Explore further: Improving the search for new schizophrenia treatments

Related Stories

Improving the search for new schizophrenia treatments

April 5, 2013
(Medical Xpress)—Controlling the symptoms of schizophrenia is the job of antipsychotic drugs which block a set of specific neural signals. But the way these drugs work can lead to a host of severe and debilitating long-term ...

Folate and vitamin B12 reduce disabling schizophrenia symptoms in some patients

March 6, 2013
Adding the dietary supplements folate and vitamin B12 to treatment with antipsychotic medication improved a core symptom component of schizophrenia in a study of more than 100 patients. The study focused on negative symptoms ...

Researchers identify new drug target for schizophrenia

August 13, 2012
(Medical Xpress) -- Researchers at Mount Sinai School of Medicine may have discovered why certain drugs to treat schizophrenia are ineffective in some patients. Published online in Nature Neuroscience, the research will pave ...

Research may explain why some people with schizophrenia do not respond to treatment

November 29, 2012
(Medical Xpress)—New research suggests that the molecular mechanism leading to schizophrenia may be different in patients who fail to respond to anti-psychotic medication compared to patients who do respond.

Patients with schizophrenia benefit from 'adherence therapy'

March 4, 2013
(Medical Xpress)—More than half of all patients suffering from schizophrenia do not take antipsychotic medication as prescribed, although this is essential for their effective treatment, according to research published ...

Experimental agent briefly eases depression rapidly in test: Works in brain like ketamine, with fewer side effects

December 11, 2012
(Medical Xpress)—A drug that works through the same brain mechanism as the fast-acting antidepressant ketamine briefly improved treatment-resistant patients' depression symptoms in minutes, with minimal untoward side effects, ...

Recommended for you

People with prosthetic arms less affected by common illusion

January 22, 2018
People with prosthetic arms or hands do not experience the "size-weight illusion" as strongly as other people, new research shows.

Study of learning and memory problems in OCD helps young people unlock potential at school

January 22, 2018
Adolescents with obsessive-compulsive disorder (OCD) have widespread learning and memory problems, according to research published today. The findings have already been used to assist adolescents with OCD obtain the help ...

Intensive behavior therapy no better than conventional support in treating teenagers with antisocial behavior

January 19, 2018
Research led by UCL has found that intensive and costly multisystemic therapy is no better than conventional therapy in treating teenagers with moderate to severe antisocial behaviour.

Babies' babbling betters brains, language

January 18, 2018
Babies are adept at getting what they need - including an education. New research shows that babies organize mothers' verbal responses, which promotes more effective language instruction, and infant babbling is the key.

College branding makes beer more salient to underage students

January 18, 2018
In recent years, major beer companies have tried to capitalize on the salience of students' university affiliations, unveiling marketing campaigns and products—such as "fan cans," store displays, and billboard ads—that ...

Inherited IQ can increase in early childhood

January 18, 2018
When it comes to intelligence, environment and education matter – more than we think.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.